ARIAD PHARMACEUTICALS INC (ARIA) Stock Price & Overview
NASDAQ:ARIA • US04033A1007
Current stock price
The current stock price of ARIA is 23.99 null. Today ARIA is up by 0.17%. In the past month the price increased by 1.24%. In the past year, price increased by 368.56%.
ARIA Key Statistics
- Market Cap
- 4.663B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.18
- Dividend Yield
- N/A
ARIA Stock Performance
ARIA Stock Chart
ARIA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to ARIA. When comparing the yearly performance of all stocks, ARIA is one of the better performing stocks in the market, outperforming 99.41% of all stocks.
ARIA Earnings
ARIA Forecast & Estimates
ARIA Financial Highlights
Over the last trailing twelve months ARIA reported a non-GAAP Earnings per Share(EPS) of -0.18. The EPS decreased by -916.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 101.23% | ||
| ROA | -5.12% | ||
| ROE | 0% | ||
| Debt/Equity | N/A |
ARIA Ownership
About ARIA
Company Profile
Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases.
Company Info
ARIAD PHARMACEUTICALS INC
26 LANDSDOWNE ST
CAMBRIDGE MA 02139
CEO: Paris Panayiotopoulos
Phone: 617-494-0400
ARIAD PHARMACEUTICALS INC / ARIA FAQ
Can you describe the business of ARIAD PHARMACEUTICALS INC?
Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases.
What is the stock price of ARIAD PHARMACEUTICALS INC today?
The current stock price of ARIA is 23.99 null. The price increased by 0.17% in the last trading session.
Does ARIAD PHARMACEUTICALS INC pay dividends?
ARIA does not pay a dividend.
What is the ChartMill technical and fundamental rating of ARIA stock?
ARIA has a ChartMill Technical rating of 10 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
Who owns ARIAD PHARMACEUTICALS INC?
You can find the ownership structure of ARIAD PHARMACEUTICALS INC (ARIA) on the Ownership tab.